Ignite Creation Date:
2024-10-26 @ 3:35 PM
Last Modification Date:
2024-10-26 @ 3:35 PM
Study NCT ID:
NCT06511063
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-07-16
Brief Title:
Antiviral Clinical Trial for Long Covid-19
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Investigating the Feasibility of Repurposing HIV Antivirals in Adults With Long Covid
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The trial will test if two repurposed HIV antivirals can reduce symptom burden in adult participants with Long Covid compared to placebo Viral infection and viral reactivation have been documented in Long Covid
Participants will be randomly allocated to receive antivirals Truvada tenofovir disoproxilemtricitabine TDFFTC Group 1 or Selzentry Group 2 or a placebo pill Group 3 taken daily for 90 days
Participants will be randomly allocated to receive antivirals Truvada tenofovir disoproxilemtricitabine TDFFTC Group 1 or Selzentry Group 2 or a placebo pill Group 3 taken daily for 90 days
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None